Effects |
Cells with high proliferation rate (stem cells, Paneth cells, enteroendocrine cells, etc.) |
Mostly fibroblasts |
Pathogenesis |
Inhibition of stem cell proliferation and differentiation. Intensification of apoptosis and intestinal epithelial stem cell impairment |
Fibroblast stimulation to proliferation and accumulation in the submucosa. Submucosal fibrosis is related to increase of collagen synthesis. Increase in secretion of hepatocyte growth factor (HGF), transforming growth factor β (TGF-β1), and cytokines. Mesenteric thrombosis and vasculitis leads to intestinal ischaemia |
Time since start of radiotherapy to onset of symptoms |
2–4 weeks |
Months – years |
Symptoms and complications |
Nausea, vomiting, diarrhoea, water and electrolyte disturbances, mucositis, dysbiosis |
Ileus, fistulas, bleeding, ulceration, perforations |
Treatment |
Conservative |
Mainly surgical |
Disease course |
Acute – resolves spontaneously after radiotherapy |
Chronic, irreversible. Natural mechanisms are not able to repair the damage |